Massive Demand Drives Avience Biomedicals IPO Subscription to 365 Times on Final Day
Avience Biomedicals, a leading diagnostics solutions provider, has seen extraordinary investor interest following the culmination of its Initial Public Offering (IPO) bidding process. The company's stock attracted overwhelming demand, witnessing a highly successful subscription rate of 365.06 times on June 22nd. This massive response highlights strong market confidence in the medical consumables sector.Subscription Highlights and Grey Market Verdict
The IPO generated immense interest across various investor segments during the three-day bidding window (June 18-22). The company offered a total of 10.44 lakh shares, seeking to mobilize Rs 30.2 crore...